当前位置:首页 - 行情中心 - 东诚药业(002675) - 财务分析 - 现金流量表

东诚药业

(002675)

  

流通市值:97.90亿  总市值:108.60亿
流通股本:7.43亿   总股本:8.25亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,841,498,819.562,088,642,906.591,351,467,618.4618,943,960.25
收到的税费返还94,095,466.375,473,869.5849,417,487.126,083,970.84
收到其他与经营活动有关的现金95,272,846.9345,742,605.3932,665,140.1314,431,295.28
经营活动现金流入的平衡项目0000
经营活动现金流入小计3,030,867,132.792,209,859,381.561,433,550,245.63659,459,226.37
购买商品、接受劳务支付的现金1,393,435,814.561,052,074,442.17797,391,790.77471,541,080.9
支付给职工以及为职工支付的现金486,620,513.34367,180,926.92257,966,030.72152,583,106.37
支付的各项税费241,080,519.7183,633,413124,122,602.6856,443,751.08
支付其他与经营活动有关的现金622,579,505.66422,024,000.34271,856,680.66144,210,123.74
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,743,716,353.262,024,912,782.431,451,337,104.83824,778,062.09
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额287,150,779.53184,946,599.13-17,786,859.2-165,318,835.72
二、投资活动产生的现金流量:
收回投资收到的现金822,673,958528,072,135.74245,604,983.7548,500,000
取得投资收益收到的现金6,233,098.334,876,396.044,025,196.95136,669.52
处置固定资产、无形资产和其他长期资产收回的现金净额716,682.04359,253.76330,000278,300
处置子公司及其他营业单位收到的现金净额-18,454,956.259,340,998.256,750,000
收到的其他与投资活动有关的现金1,646,000---
投资活动现金流入的平衡项目0000
投资活动现金流入小计831,269,738.37551,762,741.79259,301,178.9555,664,969.52
购建固定资产、无形资产和其他长期资产支付的现金456,093,958.61373,042,254.67248,890,317.47112,281,589.86
投资支付的现金1,086,717,900.78843,987,453.12480,190,600298,971,000
取得子公司及其他营业单位支付的现金3,456,315.313,456,315.313,456,315.31-
支付其他与投资活动有关的现金-8,011,4508,005,725-
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,546,268,174.71,228,497,473.1740,542,957.78411,252,589.86
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-714,998,436.33-676,734,731.31-481,241,778.83-355,587,620.34
三、筹资活动产生的现金流量:
吸收投资收到的现金689,600,000689,600,000687,988,680360,600,000
取得借款收到的现金878,181,835.2719,128,388.67660,548,355.34328,460,000
收到其他与筹资活动有关的现金8,912,727.86--34,600,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,576,694,563.061,408,728,388.671,348,537,035.34723,660,000
偿还债务支付的现金790,913,049.72609,313,298.2474,119,112.54135,467,799.93
分配股利、利润或偿付利息支付的现金217,253,332.68159,083,436.12136,379,198.636,346,448.86
支付其他与筹资活动有关的现金24,947,035.089,546,000.195,959,884.324,723,885.7
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,033,113,417.48777,942,734.51616,458,195.49146,538,134.49
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额543,581,145.58630,785,654.16732,078,839.85577,121,865.51
四、汇率变动对现金及现金等价物的影响12,148,894.687,390,759.056,890,747.752,735,307.56
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额127,882,383.46146,388,281.03239,940,949.5758,950,717.01
加:期初现金及现金等价物余额607,738,181.62607,738,181.62607,738,181.62609,981,872.62
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额735,620,565.08754,126,462.65847,679,131.19668,932,589.63
补充资料:
净利润141,425,009.68-119,928,008.66-
资产减值准备101,336,585.19-9,025,711.92-
固定资产和投资性房地产折旧136,486,970.98-70,241,719.8-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧136,486,970.98-70,241,719.8-
无形资产摊销17,852,134.53-9,628,555.86-
长期待摊费用摊销9,525,298.99-3,909,209.92-
处置固定资产、无形资产和其他长期资产的损失-302,727.5--65,276.9-
固定资产报废损失93,484.23--6,788.53-
公允价值变动损失-1,068,427.73-240,753.42-
财务费用80,325,376.9-17,439,149.51-
投资损失13,984,963.44-1,998,032.8-
递延所得税-7,520,816.93-13,041,924.31-
其中:递延所得税资产减少-6,715,351.04-13,868,685.22-
递延所得税负债增加-805,465.89--826,760.91-
存货的减少261,389,737.05-170,819,239.76-
经营性应收项目的减少-124,861,810.36--147,202,659.35-
经营性应付项目的增加-447,963,732.93--313,473,549.66-
其他95,835,413.12-21,619,878.2-
现金的期末余额735,620,565.08-847,679,131.19-
减:现金的期初余额607,738,181.62-607,738,181.62-
公告日期2025-02-272024-10-292024-08-312024-04-27
审计意见(境内)标准无保留意见
TOP↑